TRIBUNTORAJA.COM - Indrayani Umar Muchlas berbahagia. Setelah 11 tahun menanti, niatnya menunaikan ibadah haji akhirnya terwujud. Tergabung dalam Kloter 37, Indrayani satu dari 19 Jamaah Calon Haji (J ...

Indrayani, operator Siskohat Toraja Utara, naik haji usai 11 tahun menanti. Momen makin istimewa setelah ia dilantik sebagai PPPK dua hari sebelumnya ...

TRIBUNGAYO.COM, JAKARTA - Komunitas Sastra Muda Jakarta ramaikan Forum Diskusi Meja Panjang pada Kamis 22 Mei 2025, pukul 14.00 hingga 17.00 WIB. Kegiatan ini akan berlangsung di Aula Lantai 4, Pusat ...

Hong Kong-based venture capital firm ORI Capital plans to launch a new fund to invest in Chinese healthcare start-ups, as the domestic biotechnology industry experiences its own “DeepSeek moment ...

Portage Biotech's PORT-7 showed >90% tumor growth inhibition with anti-PD1 combo in a murine mesothelioma model. PORT-7 single-agent activity outperformed anti-PD1 treatment alone; first-in-human ...

Bay Area biotech company Tempest Therapeutics was once valued at more than $1 billion, but now it’s running out of gas. Last week, the cancer researcher revealed plans to lay off all but five ...

China is moving fast to dominate biotechnology, and the U.S. risks falling behind permanently unless it takes action over the next three years, a congressional commission said. Congress should ...

AmplifyBio, once one of central Ohio's most promising biotech firms, announced Friday that it has shut down. In a posting on its website, the company said the decision followed months of efforts ...

Biotechnology offers a scalable alternative, but realizing its full potential requires commitment from governments and space agencies. By harnessing biological processes such as microbial and ...

PORT-7 shows >90% tumor growth inhibition in mesothelioma models when combined with an anti-PD1 antibody. Portage plans a first-in-human trial for PORT-7 and aims to combine PORT-6 and PORT-7 to ...

Biotech companies are innovators, which could translate into growth for your portfolio. It’s important to think long term and pay particular attention to a biotech’s pipeline -- today’s out ...